BMO Capital maintains Amgen stock rating citing Tavneos concerns By Investing.com

BMO Capital maintains Amgen stock rating citing Tavneos concerns By Investing.com  Investing.com Canada

Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.